Discussion on acceptance limit of drug metabolites in quality standard
10.19778/j.chp.2024.05.017
- VernacularTitle:药物代谢产物在质量标准中可接受限度探讨
- Author:
Yunfei LIU
1
;
Lingbo WANG
;
Xiulan WU
;
Jia YU
;
Hao ZHOU
;
Lihong YANG
Author Information
1. 正大天晴药业集团股份有限公司,南京 211112
- Keywords:
related substance;
metabolites;
qualification;
acceptable limit;
quality standard;
impurity
- From:
Drug Standards of China
2024;25(5):526-528
- CountryChina
- Language:Chinese
-
Abstract:
This paper discussed how to set the limit of impurities in the quality standard when the impurities in small-molecular innovative drugs were metabolites.Firstly,through the analysis and interpretation of each relevant guideline,in combination with the review cases of FDA and EMA,found out the conditions for qualification of im-purity,and then establ ish the acceptable limit of impurities based on the test results of multiple batches,the incre-ments of production process and storage process.